Roche Bobois (RBO)
Euronext Paris · France · prices in EUR · close of 19 Oct 2026
Key indicators
| Last close | EUR 14.20 |
|---|---|
| 52-week range | 13.50 – 36.37 |
| Return, 1 month / 3 months | −25.1% / −30.7% |
| Return, 1 year / 3 years | −59.7% / −61.8% |
| Trend | Below its 200-day average |
| RSI (14) | 18 |
| Volatility (1 year) | 30.5% |
| Worst drawdown (1 year) | -60.0% |
| Average daily value traded | 0.02M EUR |
| Dividend yield | 5.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Roche Bobois is a French furniture maker and retailer based in Paris. It designs and sells high-end contemporary and classic furniture, including sofas, seating, dining furniture, bedroom pieces and home accessories, often developed with designers and offered in distinctive collections. Its customers are mainly affluent homeowners and interior design clients, and it reaches them through a network of franchised and company-owned showrooms in France and in many other countries around the world.
On this site Roche Bobois appears as a stock on the Euronext Paris (France), code RBO, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Roche Bobois (RBO) trades on the Euronext Paris in France. It last closed at EUR 14.20 on 19 October 2026.
Its price-based Market X-Ray is 31 out of 100 (a weak price profile), ranking 500 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 59.7% and over the last three months it fell 30.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 13 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -39.0% | ||
| From 52-week high | -60.0% | ||
| Momentum | 11 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -30.7% | ||
| 6-month return | -43.8% | ||
| 12-month return, skipping the last month | -46.2% | ||
| Stability (higher is calmer) | 44 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 30.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -60.0% | ||
| Liquidity | 47 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.02M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.6% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −12.1% |
|---|---|
| 1 month | −25.1% |
| 3 months | −30.7% |
| 6 months | −43.7% |
| 1 year | −59.7% |
| 3 years | −61.8% |
| 5 years | −52.4% |
Signals
| 50-day / 200-day average | 19.16 / 23.30 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.58 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Jul 2026 | EUR 0.8000 |
| 2 Jul 2025 | EUR 1.2500 |
| 3 Jul 2024 | EUR 1.2500 |
| 14 Nov 2023 | EUR 1.0000 |
| 4 Jul 2023 | EUR 1.2500 |
| 2 Dec 2022 | EUR 1.0000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.